Global Proteomics Market Size, Share, Growth Analysis, By Product(Services, Reagents & Consumables), By Technology(Microarray Instruments, X-Ray Crystallography), By Application(Drug Discovery, Clinical Diagnostics) - Industry Forecast 2023-2030

To request a free sample copy of this report, please complete the form below.

What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

License Type Top market research company in USA

File Type

Analyst Support

$5,300

BUY NOW

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

SPEAK TO AN ANALYST

FAQ's

Proteomics Market size was valued at USD 25.2 billion in 2021 and is poised to grow from USD 29.35 billion in 2022 to USD 100.17 billion by 2030, growing at a CAGR of 16.55% in the forecast period (2023-2030).

To increase their industry presence, key players are implementing various strategies such as mergers and acquisitions, geographical expansion, and strategic collaborations. Seer, Inc., for example, announced the Broad Commercial Release of The Proteograph Product Suite and the Centers of Excellence programme in January 2022. The Proteograph Product Suite provides unbiased, unrivalled access to the proteome. The method employs specially designed nanoparticles to create a game-changing product that enables rapid, thorough, and unbiased proteomics at scale. 'Bio-Rad Laboratories, Inc. ', 'GE Healthcare ', 'Creative Proteomics ', 'Thermo Fisher Scientific Inc.', 'Agilent Technologies Inc.', 'Danaher Corporation', 'Merck KGaA', 'Bruker Corporation', 'Waters Corporation', 'PerkinElmer Inc.', 'Shimadzu Corporation', 'Biognosys AG', 'Luminex Corporation', 'Promega Corporation', 'Proteome Sciences plc', 'Genedata AG', 'GenScript Biotech Corporation', 'Bioproximity LLC', 'Applied Proteomics Inc.', 'Avant Diagnostics Inc.'

Several significant discoveries were made in the field of life sciences, one of which was the completion of the human genome sequencing. The characterization of human protein was the next significant biomedicine milestone, which is a relatively new and extremely dynamic branch of science focused on evaluating gene expression at the proteome level. With limited research in proteomics to date, current proteomics can only address a few issues, such as protein identification, quantification, characterization of post-translational modifications, structure and function elucidation, and description of potential interactions.

Nanotechnology has been linked to several proteomics applications, including phosphor proteomics/metal oxide nanoparticles, nanostructured surfaces for protein separation, and array-based analytical detection of biomarker proteins. As a result, Nano proteomics, a science involving the application of proteomics techniques aided by nanotechnology, has emerged. This technique is used in conjunction with other nanotechnology applications to revolutionize proteomics, such as nano porous structures, functionalized nanoparticles, quantum dots, and polymeric nanostructures.

The global proteomics market is studied on the basis of geography as North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America dominated the industry in 2021, accounting for 45% of total revenue. This is due to increased investments in structure-based drug design, growth in omics research, demand for high-quality research tools for data reproducibility, and focus on the development of tailored treatments. Partnerships and collaborations among major companies in this region are also assisting in the market's expansion. Thermo Fisher Scientific Inc. and Symphogen, for example, collaborated to develop validated platform processes for the streamlined characterization and quality monitoring of complex therapeutic proteins.

Feedback From Our Clients